Latest Conference Coverage
What Role Do Genetics Play in Determining Alzheimer Disease Risk?
August 2nd 2019The professor of neurology and founding chair of the John T. Macdonald Foundation Department of Human Genetics at the University of Miami discussed the distinctions between Alzheimer disease risk of ethnicities that share genetic markers.
Sarah Wilson, PhD: The Burden of Normality Post-Epilepsy Surgery
August 2nd 2019The clinical neuropsychologist and head of the School of Psychological Sciences at the University of Melbourne spoke about what physicians need to provide to help patients through the adjustment period after epilepsy surgery.
Sarah Wilson, PhD: The Promise of Neurorehabilitation After Epilepsy Surgery
August 1st 2019The clinical neuropsychologist and head of the School of Psychological Sciences at the University of Melbourne discussed the early-stage research into neurorehabilitation post-epilepsy surgery, and the promise it might hold to address surgery’s long-term risks.
sTMS Proves Safe, Effective for Migraine With Medication Overuse
July 30th 2019The use of single-pulse transcranial magnetic stimulation, while already FDA-approved for acute and preventive migraine treatment, has shown that it can be effective in reducing the need for acute headache medications in patients with migraine.
Dawn Buse, PhD: Inappropriate Prescriptions in Acute, Preventive Migraine Treatment
July 30th 2019The clinical professor of neurology at Albert Einstein College of Medicine spoke to the findings of the OVERCOME study, and how recent literature has suggested that improper prescriptions and medication use in migraine have been ongoing in spite of the current recommendations.
Jeffrey L. Cummings, MD, ScD: Addressing Agitation, Psychosis in Alzheimer Disease
July 28th 2019The director emeritus of the Cleveland Clinic Lou Ruvo Center for Brain Health and vice chair of the department of brain health at the University of Nevada Las Vegas spoke about therapies under investigation for the treatment of agitation and psychosis in Alzheimer disease.
James W. Wheless, MD: Making Treatment Decisions in Epilepsy
July 26th 2019The professor and chief of pediatric neurology at Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center discussed the decision-making process for choosing interventions for patients with epilepsy, and how to keep patients adherent.
Christopher Gottschalk, MD: Long-Term Safety in Preventive Migraine Therapies
July 25th 2019The director of headache medicine and chief of general neurology at Yale Medicine discussed the long-term success the new preventive migraine therapies have shown thus far, and how the lack of safety concerns will improve how they’re utilized.
David Llewellyn, PhD: The Impact of Lifestyle Factors on Genetic Risk in Dementia
July 25th 2019The associate professor of neuroepidemiology and digital health spoke about the importance of findings from an observational study which showed that adherence to a healthy lifestyle can offset the genetic risk for dementia.
James W. Wheless, MD: The Consequences of Uncontrolled Epilepsy
July 22nd 2019The professor and chief of pediatric neurology at Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center spoke about the concerns of uncontrolled epilepsy and how to determine if a patient requires more than one treatment for their epilepsy.
Kelly Knupp, MD: Increasing Patient Curiosity About CBD in Epilepsy
July 19th 2019The pediatric neurologist and epilepsy specialist at Children’s Hospital Colorado discussed the popularity of cannabidiol from coverage in the media, and how she sees its use—and the understanding of it—evolving in the coming years.
Researchers Continue to Make In-Roads Towards Infectious Link to Alzheimer Disease
July 19th 2019The topic was the focus of a lively panel discussion and several posters at the 2019 Alzheimer’s Association International Conference, where experts in the field debated on the validity of current findings and theories.
Jonathan Voglein, MD: Epilepsy in Alzheimer Disease
July 19th 2019This data demonstrates that patients with Alzheimer disease are at an increased risk for seizures, in particular in more advanced disease stages, which emphasizes a need for seizure history assessment to inform individual therapeutic decisions and the necessity of systematic treatment studies.
Jessica Ailani, MD: Lowering the Opioid Use Rates in Migraine
July 18th 2019The director of the MedStar Georgetown Headache Center spoke about the higher-than-desired rates of opioid prescriptions for patients with migraine, and how new treatment options and provider education can help lower those numbers.
Improving Alzheimer Care in the Emergency Department: Q&A With Manish Shah, MD, MPH
July 18th 2019The professor of emergency medicine at the University of Wisconsin-Madison School of Medicine and Public Health spoke about the challenges physicians face in the emergency department when dealing with patients that are cognitively impaired.
Susan Hutchinson, MD: The Potential of the Gepant Class in Acute Migraine
July 17th 2019The director of the Orange County Migraine and Headache Center spoke about the adherence issues in acute migraine treatment and how the safety profile of investigational medications such as rimegepant and ubrogepant suggests they may be able to address them.
Jeffery Vance, MD, PhD: Role of Genetics in Distinguishing Alzheimer Risk
July 17th 2019The professor of neurology and founding chair of the John T. Macdonald Foundation Department of Human Genetics at the University of Miami spoke about how the risk of Alzheimer disease differs between ethnic groups, despite being associated with the same genetic marker.
